Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Rimiducid
TROP2-CAR-NK Cells
+2 more
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
October 24, 2023
Primary Completion Date
April 30, 2038
Completion Date
April 30, 2040
Last Updated
October 14, 2025
NCT06898450
NCT06658951
NCT05719558
NCT05101070
NCT06716138
NCT06307795
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions